Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VYNE THERAPEUTICS INC.

(VYNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about VYNE THERAPEUTICS INC.
01/19VYNE Therapeutics Completes Phase 1b Data for FMX114 for Atopic Dermatitis
MT
01/19VYNE THERAPEUTICS : Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Trea..
PU
01/19VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Tre..
AQ
01/19VYNE Therapeutics Inc. Announces Phase 1B Data for Fmx114 from Phase 1B/2A Trial for th..
CI
01/14VYNE THERAPEUTICS : Unaudited Pro Forma Condensed Consolidated Financial Information - For..
PU
01/14VYNE Therapeutics Inc. Announces Board Changes
CI
01/13Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade
MT
01/13Thinking about buying stock in Adagio Therapeutics, Vyne Therapeutics, PetVivo, BTCS In..
PR
01/13VYNE THERAPEUTICS : Divests Topical Minocycline Assets - Form 8-K
PU
01/13Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and ..
CI
01/03VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access E..
AQ
2021VYNE THERAPEUTICS INC.(NASDAQGS : VYNE) dropped from NASDAQ Biotechnology Index
CI
2021VYNE Therapeutics Shares Surge After HC Wainwright Starts Coverage at Buy
MT
2021HC Wainwright Assumes VYNE Therapeutics at Buy with $7 Price Target
MT
2021Thinking about buying stock in Del Taco Restaurants, Vyne Therapeutics, Lucid Group, AS..
PR
More most relevant news
All news about VYNE THERAPEUTICS INC.
01/19VYNE Therapeutics Completes Phase 1b Data for FMX114 for Atopic Dermatitis
MT
01/19VYNE THERAPEUTICS : Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Trea..
PU
01/19VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/19VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Tre..
AQ
01/19VYNE Therapeutics Inc. Announces Phase 1B Data for Fmx114 from Phase 1B/2A Trial for th..
CI
01/14VYNE THERAPEUTICS : Unaudited Pro Forma Condensed Consolidated Financial Information - For..
PU
01/14VYNE THERAPEUTICS INC. Change in Directors or Principal Officers, Financial Statements..
AQ
01/14VYNE Therapeutics Inc. Announces Board Changes
CI
01/14Health Care Stocks Drop Premarket Friday
MT
01/13Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade
MT
More news
News in other languages on VYNE THERAPEUTICS INC.
01/19VYNE Therapeutics achève les données de phase 1b sur le FMX114 pour la dermatite atopiq..
01/19VYNE Therapeutics Inc. annonce les données de l'essai de phase 1B/2A pour le Fmx114 dan..
01/14VYNE Therapeutics Inc. annonce des changements au conseil d'administration
01/14Les actions du secteur de la santé chutent vendredi en prémarché
01/13Les actions du secteur de la santé perdent encore du terrain alors que les biotechs vac..
01/13Journey Medical acquiert la franchise de technologie de stabilisation des molécules de ..
01/13Journey Medical Corporation acquiert deux produits topiques de minocycline approuvés pa..
2021Les actions de VYNE Therapeutics augmentent après que HC Wainwright ait décidé de les c..
2021Earnings Flash (VYNE) VYNE THERAPEUTICS affiche un chiffre d'affaires de 4,1 millions d..
2021VYNE Therapeutics recrute son premier patient dans le cadre d'un essai sur le FMX114 po..
More news
Analyst Recommendations on VYNE THERAPEUTICS INC.
2021HC Wainwright Assumes VYNE Therapeutics at Buy with $7 Price Target
MT
2021VYNE THERAPEUTICS : Northland Adjusts VYNE Therapeutics' Price Target to $6 From $12, Keep..
MT
2021VYNE THERAPEUTICS : HC Wainwright Adjusts VYNE Therapeutics' Price Target to $11 from $14,..
MT
2021VYNE THERAPEUTICS : Barclays Adjusts Price Target for VYNE Therapeutics to $15 From $12, M..
MT
More recommendations
Press releases
01/19VYNE THERAPEUTICS : Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Trea..
PU
01/19VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/19VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Tre..
AQ
01/14VYNE THERAPEUTICS : Unaudited Pro Forma Condensed Consolidated Financial Information - For..
PU
01/14VYNE THERAPEUTICS INC. Change in Directors or Principal Officers, Financial Statements..
AQ
More press releases
Upcoming event on VYNE THERAPEUTICS INC.